Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen‐induced arthritis (Q73481227)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209498%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209498%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen‐induced arthritis (English)

1 reference

https://api.crossref.org/works/10.1002/EJI.1830270623

1 September 2024

1 reference

A. Doncarli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9209498

1 September 2024

L. M. Stasiuk

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9209498

1 September 2024

C. Fournier

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9209498

1 September 2024

O. Abehsira-Amar

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9209498

1 September 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9209498

1 September 2024

publication date

1 June 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209498%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

4 November 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Feji.1830270623

1 reference

https://api.crossref.org/works/10.1002/EJI.1830270623

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.1830270623

1 September 2024

1 reference

https://api.crossref.org/works/10.1002/EJI.1830270623

European Journal of Immunology

1 September 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209498%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209498%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209498%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

1451-1458

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209498%20AND%20SRC:MED&resulttype=core&format=json

Autoimmunity to type II collagen an experimental model of arthritis

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Immunisation against heterologous type II collagen induces arthritis in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Collagen autoimmunity and arthritis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

The role of the B cells in the adoptive transfer of collagen-induced arthritis from DBA/1 (H-2q) to SCID (H-2d) mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Therapy against murine collagen-induced arthritis with T cell receptor Vβ-specific antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Characterization of the T cell receptor repertoire causing collagen arthritis in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

T helper cell subsets in insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Role of cytokines in experimental arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Treatment with gamma-interferon triggers the onset of collagen arthritis in mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

The effect of treatment with interferon-gamma on type II collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Biphasic effect of interferon-gamma in murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Interaction between proteoglycan subunit and type II collagen from bovine nasal cartilage, and the preferential binding of proteoglycan subunit to type I collagen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Biochemical and physiochemical characterization of pepsin-solubilized type-II collagen from bovine articular cartilage

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Interleukin-10 inhibition of the progression of established collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Elevated interleukin-10 levels in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Immunoregulatory role of interleukin 10 in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Regulation of the balance of cytokine production and the signal transducer and activator of transcription (STAT) transcription factor activity by cytokines and inflammatory synovial fluids

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Mast cell numbers in rheumatoid synovial tissues. Correlations with quantitative measures of lymphocytic infiltration and modulation by antiinflammatory therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Characterization and functional studies of rheumatoid synovial mast cells. Activation by secretagogues, anti-IgE, and a histamine-releasing lymphokine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4,

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270623

7 January 2021

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209498%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209498%20AND%20SRC:MED&resulttype=core&format=json